Preclinical disposition and pharmacokinetics-pharmacodynamic modeling of biomarker response and tumour growth inhibition in xenograft mouse models of G-573, a MEK inhibitor

By Choo Edna F.   Belvin Marcia   Chan Jocelyn   Hoeflich Klaus   Orr Christine   Robarge Kirk   Yang Xiaoye   Zak Mark   Boggs Jason  

Xenobiotica, Vol. 40, Iss. 11, 2010-11 ,pp. : 751-762

Informa Healthcare

Access to resources Recommend Favorite

Preclinical stereoselective disposition and toxicokinetics of two novel MET inhibitors

By Liederer Bianca M.   Liu Xingrong   Berezhkovskiy Leonid M.   Cain Gary   Ding Xiao   Gaudino John   Kaus Robert   Plise Emile G.   Sutherlin Daniel P.   Harstad Eric B.  

Xenobiotica, Vol. 42, Iss. 5, 2012-05 ,pp. : 456-465

Informa Healthcare

Access to resources Recommend Favorite

Biomarkers for diagnosing and monitoring autoimmune diseases

By Prince Harry  

Biomarkers, Vol. 10, Iss. 1, 2005-11 ,pp. : 44-49

Informa Healthcare

Access to resources Recommend Favorite

Pre-clinical assessment of DRF 4367, a novel COX-2 inhibitor: Evaluation of pharmacokinetics, absolute oral bioavailability and metabolism in mice and comparative inter-species in vitro metabolism

By Bhamidipati R   Mujeeb S   Dravid P. V   Khan A. A   Singh S. K   Rao Y. K   Mullangi R   Srinivas N. R  

Xenobiotica, Vol. 35, Iss. 3, 2005-03 ,pp. : 253-271

Informa Healthcare

Access to resources Recommend Favorite

Potential biomarkers of an exaggerated response to endotoxemia

By Kasthuri R. S.   Wroblewski M.   Jilma B.   Key N. S.   Nelsestuen G. L.  

Biomarkers, Vol. 12, Iss. 3, 2007-05 ,pp. : 287-302

Informa Healthcare

Access to resources Recommend Favorite